DataMeds AI, Inc. (MEDS): Revenue

Annual figures by period end, from SEC filings.

$23.34M

Year ended 2025-12-31

$8.02M

Trailing 12 months to 2026-06-30

2024-12-31 Revenue (USD) 2025-12-31

Period ended	Revenue	Change YoY	Source filing
2025-12-31	$23.34M	+28.7%	2026-03-20, From 2025-01-01
2024-12-31	$18.13M	n/a	2026-03-20, From 2024-01-01

Revenue at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Revenue	Change YoY
DataMeds AI, Inc. (MEDS)	2025-12-31	$23.34M	+28.7%
Cosmos Health Inc. (COSM)	2025-12-31	$65.27M	+19.9%
Stemtech Corp (STEK)	2025-12-31	$2.88M	-43.1%
HWH International Inc. (ESYN)	2025-12-31	$866.9K	-30.8%
Nu Skin Enterprises, Inc. (NUS)	2025-12-31	$1.49B	-14.3%
Herbalife Ltd. (HLF)	2025-12-31	$5.04B	+0.9%
Cardinal Health Inc (CAH)	2026-06-30	$254.25B	+14.2%
Cencora, Inc. (COR)	2025-09-30	$321.33B	+9.3%
McKesson Corp (MCK)	2026-03-31	$403.43B	+12.4%

Compare MEDS, COSM, STEK, ESYN side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗